148 related articles for article (PubMed ID: 10407062)
21. Advanced glycation end products in diabetic corneas.
Kaji Y; Usui T; Oshika T; Matsubara M; Yamashita H; Araie M; Murata T; Ishibashi T; Nagai R; Horiuchi S; Amano S
Invest Ophthalmol Vis Sci; 2000 Feb; 41(2):362-8. PubMed ID: 10670463
[TBL] [Abstract][Full Text] [Related]
22. Creatine plays a direct role as a protein modifier in the formation of a novel advanced glycation end product.
Miyazaki K; Nagai R; Horiuchi S
J Biochem; 2002 Oct; 132(4):543-50. PubMed ID: 12359068
[TBL] [Abstract][Full Text] [Related]
23. Pentosidine accumulates in the aging vitreous body: a gender effect.
van Deemter M; Ponsioen TL; Bank RA; Snabel JM; van der Worp RJ; Hooymans JM; Los LI
Exp Eye Res; 2009 Jun; 88(6):1043-50. PubMed ID: 19450456
[TBL] [Abstract][Full Text] [Related]
24. Immunohistochemical localization of advanced glycation end products in pinguecula.
Kaji Y; Oshika T; Amano S; Okamoto F; Koito W; Horiuchi S
Graefes Arch Clin Exp Ophthalmol; 2006 Jan; 244(1):104-8. PubMed ID: 16034606
[TBL] [Abstract][Full Text] [Related]
25. Immunohistochemical detection of imidazolone, a novel advanced glycation end product, in kidneys and aortas of diabetic patients.
Niwa T; Katsuzaki T; Miyazaki S; Miyazaki T; Ishizaki Y; Hayase F; Tatemichi N; Takei Y
J Clin Invest; 1997 Mar; 99(6):1272-80. PubMed ID: 9077536
[TBL] [Abstract][Full Text] [Related]
26. Localization of identified advanced glycation end-product structures, N epsilon(carboxymethyl)lysine and pentosidine, in age-related inclusions in human brains.
Kimura T; Takamatsu J; Miyata T; Miyakawa T; Horiuchi S
Pathol Int; 1998 Aug; 48(8):575-9. PubMed ID: 9736403
[TBL] [Abstract][Full Text] [Related]
27. Age-related increase in an advanced glycation end product in penile tissue.
Jiaan DB; Seftel AD; Fogarty J; Hampel N; Cruz W; Pomerantz J; Zuik M; Monnier VM
World J Urol; 1995; 13(6):369-75. PubMed ID: 9116757
[TBL] [Abstract][Full Text] [Related]
28. Increased pentosidine, an advanced glycation end product, in plasma and synovial fluid from patients with rheumatoid arthritis and its relation with inflammatory markers.
Miyata T; Ishiguro N; Yasuda Y; Ito T; Nangaku M; Iwata H; Kurokawa K
Biochem Biophys Res Commun; 1998 Mar; 244(1):45-9. PubMed ID: 9514872
[TBL] [Abstract][Full Text] [Related]
29. Accumulation of imidazolone, pentosidine and N(epsilon)-(carboxymethyl)lysine in hippocampal CA4 pyramidal neurons of aged human brain.
Jono T; Kimura T; Takamatsu J; Nagai R; Miyazaki K; Yuzuriha T; Kitamura T; Horiuchi S
Pathol Int; 2002 Sep; 52(9):563-71. PubMed ID: 12406185
[TBL] [Abstract][Full Text] [Related]
30. Two immunochemical assays to measure advanced glycation end-products in serum from dialysis patients.
Zhang X; Frischmann M; Kientsch-Engel R; Steinmann K; Stopper H; Niwa T; Pischetsrieder M
Clin Chem Lab Med; 2005; 43(5):503-11. PubMed ID: 15899672
[TBL] [Abstract][Full Text] [Related]
31. Immunohistochemical distribution and subcellular localization of three distinct specific molecular structures of advanced glycation end products in human tissues.
Ling X; Sakashita N; Takeya M; Nagai R; Horiuchi S; Takahashi K
Lab Invest; 1998 Dec; 78(12):1591-606. PubMed ID: 9881959
[TBL] [Abstract][Full Text] [Related]
32. Bruch's membrane aging decreases phagocytosis of outer segments by retinal pigment epithelium.
Sun K; Cai H; Tezel TH; Paik D; Gaillard ER; Del Priore LV
Mol Vis; 2007 Dec; 13():2310-9. PubMed ID: 18199972
[TBL] [Abstract][Full Text] [Related]
33. Renal proximal tubular metabolism of protein-linked pentosidine, an advanced glycation end product.
Asano M; Fujita Y; Ueda Y; Suzuki D; Miyata T; Sakai H; Saito A
Nephron; 2002 Aug; 91(4):688-94. PubMed ID: 12138274
[TBL] [Abstract][Full Text] [Related]
34. Contents of pentosidine in the tissue of the intervertebral disc as an indicator of the human age.
Pillin A; Pudil F; Bencko V; Bezdícková D
Soud Lek; 2007 Oct; 52(4):60-4. PubMed ID: 18189072
[TBL] [Abstract][Full Text] [Related]
35. Age-related accumulation of pentosidine in aggrecan and collagen from normal and degenerate human intervertebral discs.
Sivan SS; Tsitron E; Wachtel E; Roughley P; Sakkee N; van der Ham F; Degroot J; Maroudas A
Biochem J; 2006 Oct; 399(1):29-35. PubMed ID: 16787390
[TBL] [Abstract][Full Text] [Related]
36. Renal catabolism of advanced glycation end products: the fate of pentosidine.
Miyata T; Ueda Y; Horie K; Nangaku M; Tanaka S; van Ypersele de Strihou C; Kurokawa K
Kidney Int; 1998 Feb; 53(2):416-22. PubMed ID: 9461101
[TBL] [Abstract][Full Text] [Related]
37. N (epsilon)-(carboxymethyl)lysine protein adduct is a major immunological epitope in proteins modified with advanced glycation end products of the Maillard reaction.
Ikeda K; Higashi T; Sano H; Jinnouchi Y; Yoshida M; Araki T; Ueda S; Horiuchi S
Biochemistry; 1996 Jun; 35(24):8075-83. PubMed ID: 8672512
[TBL] [Abstract][Full Text] [Related]
38. Kinetics of nonenzymatic glycation of ribonuclease A leading to advanced glycation end products. Paradoxical inhibition by ribose leads to facile isolation of protein intermediate for rapid post-Amadori studies.
Khalifah RG; Todd P; Booth AA; Yang SX; Mott JD; Hudson BG
Biochemistry; 1996 Apr; 35(15):4645-54. PubMed ID: 8664253
[TBL] [Abstract][Full Text] [Related]
39. Increased collagen-linked pentosidine levels and advanced glycosylation end products in early diabetic nephropathy.
Beisswenger PJ; Moore LL; Brinck-Johnsen T; Curphey TJ
J Clin Invest; 1993 Jul; 92(1):212-7. PubMed ID: 8325987
[TBL] [Abstract][Full Text] [Related]
40. Maillard reaction-mediated molecular damage to extracellular matrix and other tissue proteins in diabetes, aging, and uremia.
Monnier VM; Sell DR; Nagaraj RH; Miyata S; Grandhee S; Odetti P; Ibrahim SA
Diabetes; 1992 Oct; 41 Suppl 2():36-41. PubMed ID: 1526333
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
